Indian benchmark indices, the BSE Sensex and NSE Nifty, are set to open in the positive terrain on Tuesday, taking firm cues from their Asian peers. At 8:10 a.m., GIFT Nifty futures were up 45 points to 24,620, indicating a positive start for the key indices.

Investors will closely monitor key triggers such as developments in U.S.-India trade negotiations, foreign fund flows, corporate earnings, and the upcoming meeting between U.S. President Donald Trump and Russian President Vladimir Putin on August 15.

On Monday, the Indian equity market ended on a strong note, rebounding from a three-month low hit in the previous session, aided by fresh buying by foreign as well as domestic institutional investors. The S&P BSE Sensex climbed 746.29 points to close at 80,604.08, while the NSE Nifty50 added 221.75 points to settle at 24,585.05.

Among the sectoral indices, Nifty PSU Bank, Realty, Auto, and Healthcare were top gainers. Barring Nifty Consumer Durables, all indices closed in the positive terrain.

U.S. stocks end lower ahead of key inflation data

Wall Street closed lower on Monday as investors turned cautious ahead of key inflation data due later this week. The Dow Jones Industrial Average fell 0.45%, the S&P 500 slipped 0.25%, and the Nasdaq Composite declined 0.3%.

The consumer price index (CPI) for July is set to be released on Tuesday, with many economists expecting a 0.2% month-on-month increase and a 2.8% annual rise. Stronger-than-expected inflation could dampen hopes of a rate cut by the Federal Reserve at its September policy meeting. These inflation figures come just ahead of the Fed’s annual Jackson Hole symposium in Wyoming from August 21-23, which may give a signal about the central bank’s next move.

Asian markets up on U.S.-China tariff truce; Japan’s Nikkei hits record high

Asian stocks witnessed strong buying on Tuesday as sentiment was lifted after the U.S.-China trade truce extension overnight. Japan’s Nikkei 225, which has already signed a trade deal with the U.S., hit a record high, while equity markets in Hong Kong and Singapore were trading marginally lower.

Japan’s Nikkei 225 rallied as much as 2.5%, China’s Shanghai Composite climbed 0.4%, while South Korea’s KOSPI and Indonesia’s Jakarta Composite surged up to 0.8%. Among others, Australia’s ASX 200 was up by 0.15% ahead of the Reserve Bank of Australia's rate verdict.

On the other hand, Hong Kong’s Hang Seng and Singapore’s Straits Times were down by 0.25% each.

Stocks to watch

Q1 results: ONGC, Hindalco Industries, Hindustan Aeronautics, Rail Vikas Nigam, Apollo Hospitals Enterprise, NSDL, Bharat Dynamics, Suzlon Energy, Zydus Lifesciences, Nykaa parent FSN E-Commerce Ventures, Honasa Consumer, Alkem Laboratories, Jindal Steel & Power, Abbott India, Dr Agarwals Health Care, Dr Agarwals Eye Hospital,  Jyothy Labs, Karnataka Bank, Natco Pharma, Nazara Technologies, NHPC, NMDC, Oil India, Rashtriya Chemicals and Fertilizers,  Senco Gold,  and VA Tech Wabag will announce their June quarter earnings today.

Bata India: The footwear manufacturing company posted a 70.1% year-on-year (YoY) decline in consolidated net profit to ₹52 crore in Q1 FY26, compared to ₹174 crore in the same period last year. Revenue was marginally lower at ₹941.8 crore, down 0.3% from ₹944.6 crore a year ago.

Ashoka Buildcon: The highway development company reported a 44.6% year-on-year rise in consolidated net profit at ₹217.3 crore in June quarter of FY26, compared to ₹150.3 crore in the same quarter last year. Revenue, however, declined 23.5% to ₹1,887 crore from ₹2,465 crore a year ago.

Muthoot Microfin: The NBFC reported a 94.5% drop in consolidated net profit to ₹6.2 crore in Q1 FY26, from ₹113 crore a year ago. Net interest income (NII) fell 16% to ₹309 crore from ₹370 crore in the same quarter last year.

Som Distilleries: The alcoholic beverages manufacturers posted a 3.7% increase in consolidated net profit to ₹42 crore in Q1 FY26, against ₹40.5 crore in the year-ago period. Revenue rose 3% to ₹528.4 crore from ₹513.4 crore in Q1 FY25.

Man Industries: The company saw its consolidated net profit rising by 45.2% YoY to ₹27.6 crore in Q1 FY26, compared to ₹19 crore in the same period last year. Revenue edged down 0.9% to ₹742.1 crore from ₹749 crore a year earlier.

Pfizer: The drug maker has introduced its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) in India, aimed at adult immunisation against 20 serotypes that cause most invasive and non-invasive pneumococcal diseases.

Indian Hotels: The Tata group company will acquire controlling stakes in ANK Hotels and Pride Hospitality for up to ₹204 crore.

Medi Assist: The company’s promoter, Bessemer India, is expected to sell up to a 4% stake through a block deal valued at around ₹560 crore.

(DISCLAIMER: The views and opinions expressed by investment experts on fortuneindia.com are either their own or of their organisations, but not necessarily that of fortuneindia.com and its editorial team. Readers are advised to consult certified experts before taking investment decisions.)